3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Histiocytic Sarcoma
1
Interventions
Gemcitabine
15
Cisplatin
13
durvalumab
12
pembrolizumab
10
Oxaliplatin
8
Magnetic Resonance Spectroscopy
8
Biopsy
7
Specimen Handling
6
Leucovorin
6
Fluorouracil
5
Paclitaxel
4
Folfox protocol
4
futibatinib
3
Taxes
3
Radiation
3
Nivolumab
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
tislelizumab
2
pemigatinib
2
olaparib
2
lenvatinib
2
fludarabine
2
dehydroftorafur
2
Radiation Dose Hypofractionation
2
Platinum
2
Liver Transplantation
2
Fluorodeoxyglucose F18
2
Floxuridine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
LY3023414
×
90 days
×
Clear all
No trials found.